CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton By: Benzinga via Benzinga July 10, 2015 at 06:52 AM EDT CNBC's Biotechnology and Pharmaceuticals reporter Meg Tirrel spoke on Fast Money about potential takeover targets for Gilead Sciences, ... Read More >> Related Stocks: Bristol-Myers Squibb Celgene Corp Gilead Sciences Intercept Pharmaceuticals Vertex Pharmaceuticals